Keith S Kaye

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 27

Top Topics

Urinary Tract Infection

Multidrug Resistant

Candida Albicans

Top Venues

Open forum infectious diseases

The Journal of antimicrobial chemotherapy

Future microbiology

Infection control and hospital epidemiology

This page only lists publications with an associated author ORCID identifier.

Publications

Gregory Weston, Abhigya Giri, Lauren Komarow, Lizhao Ge, Keri R Baum, Erin Abbenante, Jason C Gallagher, Lindsey B Gottlieb, Keith S Kaye, Angela C Kim, W Charles Huskins, Marcus J Zervos, Erica Herc, Robin Patel, David Van Duin, Yohei Doi
Clinical outcomes in patients infected with ertapenem-only-resistant Enterobacterales versus multi-carbapenem-resistant Enterobacterales. The Journal of antimicrobial chemotherapy 79 (8) (2024)
Gregory Weston, Abhigya Giri, Lauren Komarow, Lizhao Ge, Keri R Baum, Erin Abbenante, Jason C Gallagher, Lindsey B Gottlieb, Keith S Kaye, Angela C Kim, W Charles Huskins, Marcus J Zervos, Erica Herc, Robin Patel, David Van Duin, Yohei Doi
Clinical outcomes in patients infected with ertapenem-only-resistant Enterobacterales versus multi-carbapenem-resistant Enterobacterales. The Journal of antimicrobial chemotherapy (2024)
Gregory Weston, Abhigya Giri, Lauren Komarow, Lizhao Ge, Keri R Baum, Erin Abbenante, Jason C Gallagher, Lindsey B Gottlieb, Keith S Kaye, Angela C Kim, W Charles Huskins, Marcus J Zervos, Erica Herc, Robin Patel, David Van Duin, Yohei Doi
Clinical outcomes in patients infected with ertapenem-only-resistant Enterobacterales versus multi-carbapenem-resistant Enterobacterales. The Journal of antimicrobial chemotherapy (2024)
Thomas P Lodise, Keith S Kaye, Anne Santerre Henriksen, Gunnar Kahlmeter
Review of the In Vitro Microbiological Activity of Mecillinam Against Common Uropathogens in Uncomplicated Urinary Tract Infection: Focus on Resistant Pathogens. Open forum infectious diseases 11 (6) (2024)
Gregory Weston, Abhigya Giri, Lauren Komarow, Lizhao Ge, Keri R Baum, Erin Abbenante, Jason C Gallagher, Lindsey B Gottlieb, Keith S Kaye, Angela C Kim, W Charles Huskins, Marcus J Zervos, Erica Herc, Robin Patel, David Van Duin, Yohei Doi
Clinical outcomes in patients infected with ertapenem-only-resistant Enterobacterales versus multi-carbapenem-resistant Enterobacterales. The Journal of antimicrobial chemotherapy 79 (8) (2024)
Walaiporn Wangchinda, Keith S Kaye, Twisha S Patel, Owen R Albin, Louis Saravolatz, Joshua G Petrie, Jason M Pogue
A comparison of strategies for identifying patients at risk for carbapenem-resistant or extended β-lactam-resistant Pseudomonas aeruginosa. The Journal of antimicrobial chemotherapy 79 (6) (2024)
Sarah M McLeod, John P O'Donnell, Navaneeth Narayanan, John P Mills, Keith S Kaye
Sulbactam-durlobactam: a β-lactam/β-lactamase inhibitor combination targeting Acinetobacter baumannii . Future microbiology 19 (7) (2024)
Sarah M McLeod, John P O'Donnell, Navaneeth Narayanan, John P Mills, Keith S Kaye
Sulbactam-durlobactam: a β-lactam/β-lactamase inhibitor combination targeting Acinetobacter baumannii . Future microbiology 19 (7) (2024)
Thomas P Lodise, Keith S Kaye, Anne Santerre Henriksen, Gunnar Kahlmeter
Review of the In Vitro Microbiological Activity of Mecillinam Against Common Uropathogens in Uncomplicated Urinary Tract Infection: Focus on Resistant Pathogens. Open forum infectious diseases 11 (6) (2024)
Walaiporn Wangchinda, Keith S Kaye, Twisha S Patel, Owen R Albin, Louis Saravolatz, Joshua G Petrie, Jason M Pogue
A comparison of strategies for identifying patients at risk for carbapenem-resistant or extended β-lactam-resistant Pseudomonas aeruginosa. The Journal of antimicrobial chemotherapy 79 (6) (2024)
Sarah M McLeod, John P O'Donnell, Navaneeth Narayanan, John P Mills, Keith S Kaye
Sulbactam-durlobactam: a β-lactam/β-lactamase inhibitor combination targeting Acinetobacter baumannii . Future microbiology (2024)
Sarah M McLeod, John P O'Donnell, Navaneeth Narayanan, John P Mills, Keith S Kaye
Sulbactam-durlobactam: a β-lactam/β-lactamase inhibitor combination targeting Acinetobacter baumannii . Future microbiology 19 (7) (2024)
Sarah M McLeod, John P O'Donnell, Navaneeth Narayanan, John P Mills, Keith S Kaye
Sulbactam-durlobactam: a β-lactam/β-lactamase inhibitor combination targeting Acinetobacter baumannii . Future microbiology (2024)
Thomas P Lodise, Keith S Kaye, Anne Santerre Henriksen, Gunnar Kahlmeter
Review of the In Vitro Microbiological Activity of Mecillinam Against Common Uropathogens in Uncomplicated Urinary Tract Infection: Focus on Resistant Pathogens. Open forum infectious diseases 11 (6) (2024)
Walaiporn Wangchinda, Keith S Kaye, Twisha S Patel, Owen R Albin, Louis Saravolatz, Joshua G Petrie, Jason M Pogue
A comparison of strategies for identifying patients at risk for carbapenem-resistant or extended β-lactam-resistant Pseudomonas aeruginosa. The Journal of antimicrobial chemotherapy (2024)
Nikki N Tran, Ryan P Mynatt, Keith S Kaye, Jing J Zhao, Jason M Pogue
Clinical Outcomes With Extended Versus Intermittent Infusion of Anti-Pseudomonal Beta-Lactams in Patients With Gram-Negative Bacteremia. Open forum infectious diseases 10 (4) (2023)
Deborah S Yokoe, Sonali D Advani, Deverick J Anderson, Hilary M Babcock, Michael Bell, Sean M Berenholtz, Kristina A Bryant, Niccolò Buetti, Michael S Calderwood, David P Calfee, Valerie M Deloney, Erik R Dubberke, Katherine D Ellingson, Neil O Fishman, Dale N Gerding, Janet B Glowicz, Mary K Hayden, Keith S Kaye, Larry K Kociolek, Emily Landon, Elaine L Larson, Anurag N Malani, Jonas Marschall, Jennifer Meddings, Leonard A Mermel, Payal K Patel, Trish M Perl, Kyle J Popovich, Joshua K Schaffzin, Edward Septimus, Kavita K Trivedi, Robert A Weinstein, Lisa L Maragakis
Introduction to A Compendium of Strategies to Prevent Healthcare-Associated Infections In Acute-Care Hospitals: 2022 Updates . Infection control and hospital epidemiology 44 (10) (2023)
Arsheena Yassin, Mariya Huralska, Jason M Pogue, Deepali Dixit, Robert G Sawyer, Keith S Kaye
State of the Management of Infections Caused by Multidrug-Resistant Gram-Negative Organisms. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2023)
Nikki N Tran, Ryan P Mynatt, Keith S Kaye, Jing J Zhao, Jason M Pogue
Clinical Outcomes With Extended Versus Intermittent Infusion of Anti-Pseudomonal Beta-Lactams in Patients With Gram-Negative Bacteremia. Open forum infectious diseases 10 (4) (2023)
Minggui Wang, Lizhao Ge, Liang Chen, Lauren Komarow, Blake M Hanson, Jinnethe Reyes, Eric Cober, Thamer Alenazi, Zhiyong Zong, Qing Xie, Zhengyin Liu, Lanjuan Li, Yunsong Yu, Hainv Gao, Souha S Kanj, Jairo Figueroa, Erica Herc, Ezequiel Cordova, Gregory Weston, Paul Ananth Tambyah, Julia Garcia-Diaz, Keith S Kaye, Sorabh Dhar, Jose M Munita, Robert A Salata, Samuel Vilchez, Martin E Stryjewski, Maria Virginia Villegas Botero, Alina Iovleva, Scott R Evans, Keri Baum, Carol Hill, Barry N Kreiswirth, Robin Patel, David L Paterson, Cesar A Arias, Robert A Bonomo, Henry F Chambers, Vance G Fowler, Michael J Satlin, David Van Duin, Yohei Doi, null null
Clinical Outcomes and Bacterial Characteristics of Carbapenem-Resistant Acinetobacter baumannii Among Patients from Different Global Regions. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2023)
Brian M Schmidt, Keith S Kaye, David G Armstrong, Pradipta R Ray
Empirical Antibiotic Therapy in Diabetic Foot Ulcer Infection Increases Hospitalization. Open forum infectious diseases 10 (10) (2023)
Barbara W Trautner, Keith S Kaye, Vikas Gupta, Aruni Mulgirigama, Fanny S Mitrani-Gold, Nicole E Scangarella-Oman, Kalvin Yu, Gang Ye, Ashish V Joshi
Risk Factors Associated With Antimicrobial Resistance and Adverse Short-Term Health Outcomes Among Adult and Adolescent Female Outpatients With Uncomplicated Urinary Tract Infection. Open forum infectious diseases 9 (12) (2022)
Evan J Zasowski, Trang D Trinh, Kimberly C Claeys, Abdalhamid M Lagnf, Sahil Bhatia, Kenneth P Klinker, Michael P Veve, Sandy J Estrada, Scott T Johns, Adam J Sawyer, Vanthida Huang, Brandi LaFrance, Donald P Levine, Keith S Kaye, Susan L Davis, Michael J Rybak
Multicenter Cohort Study of Ceftaroline Versus Daptomycin for Treatment of Methicillin-Resistant Staphylococcus aureus Bloodstream Infection. Open forum infectious diseases 9 (3) (2021)
Brian T Tsuji, Jason M Pogue, Alexandre P Zavascki, Mical Paul, George L Daikos, Alan Forrest, Daniele R Giacobbe, Claudio Viscoli, Helen Giamarellou, Ilias Karaiskos, Donald Kaye, Johan W Mouton, Vincent H Tam, Visanu Thamlikitkul, Richard G Wunderink, Hsin-Hui Shen, Roger L Nation, Keith S Kaye
International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP). Pharmacotherapy 39 (1) (2020)
Xueliang Hua, Chen Li, Jason M Pogue, Varun S Sharma, Ilias Karaiskos, Keith S Kaye, Brian T Tsuji, Phillip J Bergen, Yan Zhu, Jiangning Song, Hsin-Hui Shen
Correction: ColistinDose, a Mobile App for Determining Intravenous Dosage Regimens of Colistimethate in Critically Ill Adult Patients: Clinician-Centered Design and Development Study. JMIR mHealth and uHealth 8 (12) (2020)
Xueliang Hua, Chen Li, Jason M Pogue, Varun S Sharma, Ilias Karaiskos, Keith S Kaye, Brian T Tsuji, Phillip J Bergen, Yan Zhu, Jiangning Song, Hsin-Hui Shen
ColistinDose, a Mobile App for Determining Intravenous Dosage Regimens of Colistimethate in Critically Ill Adult Patients: Clinician-Centered Design and Development Study. JMIR mHealth and uHealth 8 (12) (2020)
Jiajun Liu, Keith S Kaye, Nicholas J Mercuro, Susan L Davis, Twisha S Patel, Lindsay A Petty, Gwendolyn M Pais, Marc H Scheetz
It is time to define antimicrobial never events. Infection control and hospital epidemiology 40 (2) (2018)